Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Richard N van Zyl-Smit, Kenneth R Chapman, Huib AM Kerstjens, Christian Gessner, Hironori Sagara, Ana-Maria Tanase, Motoi Hosoe, Abhijit Pethe, David Lawrence, Hanns-Christian Tillmann & Peter D’Andrea. (2023) Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma. Journal of Asthma and Allergy 16, pages 123-134.
Read now
Read now
Articles from other publishers (2)
Corrado Pelaia, Giada Procopio, Fioramante Lello Rotundo, Maria Rosaria Deodato, Anna Ferrante Bannera, Francesco Giuseppe Tropea, Anna Cancelliere, Alessandro Vatrella & Girolamo Pelaia. (2023) Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 17, pages 175346662311557.
Crossref
Crossref
Luigi La Via, Filippo Sanfilippo, Giuseppe Cuttone, Veronica Dezio, Monica Falcone, Serena Brancati, Claudia Crimi & Marinella Astuto. (2022) Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies. European Journal of Clinical Pharmacology 78:10, pages 1613-1622.
Crossref
Crossref